Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach
Background Clinical pharmacy quality indicators are often non-uniform and measure individual activities not linked to outcomes. Aim To define a consensus agreed pharmaceutical care bundle and patient outcome measures across an entire state health service. Method A four-round modified-Delphi approach with state Directors of Pharmacy was performed (n = 25). They were asked to rate on a 5-point Likert scale the relevance and measurability of 32 inpatient clinical pharmacy quality indicators and outcome measures. They also ranked clinical pharmacy activities in order from perceived most to least beneficial. Based upon these results, pharmaceutical care bundles consisting of multiple clinical pharmacy activities were formed, and relevance and measurability assessed. Results Response rate ranged from 40 to 60%. Twenty-six individual clinical pharmacy quality indicators reached consensus. The top ranked clinical pharmacy quality indicator was ‘proportion of patients where a pharmacist documents an accurate list of medicines during admission’. There were nine pharmaceutical care bundles formed consisting between 3 and 7 activities. Only one pharmaceutical care bundle reached consensus: medication history, adverse drug reaction/allergy documentation, admission and discharge medication reconciliation, medication review, provision of medicines education and provision of a medication list on discharge. Sixteen outcome measures reached consensus. The top ranked were hospital acquired complications, readmission due to medication misadventure and unplanned readmission within 10 days. Conclusion Consensus has been reached on one pharmaceutical care bundle and sixteen outcomes to monitor clinical pharmacy service delivery. The next step is to measure the extent of pharmaceutical care bundle delivery and the link to patient outcomes..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
International journal of clinical pharmacy - 46(2024), 2 vom: 19. Jan., Seite 451-462 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Canning, Martin Luke [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Bundle |
| Anmerkungen: |
© Crown 2024 |
|---|
| doi: |
10.1007/s11096-023-01681-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055265464 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055265464 | ||
| 003 | DE-627 | ||
| 005 | 20240325060944.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240325s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11096-023-01681-y |2 doi | |
| 035 | |a (DE-627)SPR055265464 | ||
| 035 | |a (SPR)s11096-023-01681-y-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Canning, Martin Luke |e verfasserin |0 (orcid)0000-0002-6216-8728 |4 aut | |
| 245 | 1 | 0 | |a Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Crown 2024 | ||
| 520 | |a Background Clinical pharmacy quality indicators are often non-uniform and measure individual activities not linked to outcomes. Aim To define a consensus agreed pharmaceutical care bundle and patient outcome measures across an entire state health service. Method A four-round modified-Delphi approach with state Directors of Pharmacy was performed (n = 25). They were asked to rate on a 5-point Likert scale the relevance and measurability of 32 inpatient clinical pharmacy quality indicators and outcome measures. They also ranked clinical pharmacy activities in order from perceived most to least beneficial. Based upon these results, pharmaceutical care bundles consisting of multiple clinical pharmacy activities were formed, and relevance and measurability assessed. Results Response rate ranged from 40 to 60%. Twenty-six individual clinical pharmacy quality indicators reached consensus. The top ranked clinical pharmacy quality indicator was ‘proportion of patients where a pharmacist documents an accurate list of medicines during admission’. There were nine pharmaceutical care bundles formed consisting between 3 and 7 activities. Only one pharmaceutical care bundle reached consensus: medication history, adverse drug reaction/allergy documentation, admission and discharge medication reconciliation, medication review, provision of medicines education and provision of a medication list on discharge. Sixteen outcome measures reached consensus. The top ranked were hospital acquired complications, readmission due to medication misadventure and unplanned readmission within 10 days. Conclusion Consensus has been reached on one pharmaceutical care bundle and sixteen outcomes to monitor clinical pharmacy service delivery. The next step is to measure the extent of pharmaceutical care bundle delivery and the link to patient outcomes. | ||
| 650 | 4 | |a Bundle |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Clinical pharmacy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Consensus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Key performance indicator |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Medicines management |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Outcomes |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pharmaceutical care |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pharmacy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Quality |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Quality indicator |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Barras, Michael |4 aut | |
| 700 | 1 | |a McDougall, Ross |4 aut | |
| 700 | 1 | |a Yerkovich, Stephanie |0 (orcid)0000-0003-4163-4782 |4 aut | |
| 700 | 1 | |a Coombes, Ian |4 aut | |
| 700 | 1 | |a Sullivan, Clair |0 (orcid)0000-0003-2475-9989 |4 aut | |
| 700 | 1 | |a Whitfield, Karen |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical pharmacy |d Springer International Publishing, 2011 |g 46(2024), 2 vom: 19. Jan., Seite 451-462 |h Online-Ressource |w (DE-627)SPR055265332 |w (DE-600)2601204-2 |w (DE-576)34126718X |x 2210-7711 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2024 |g number:2 |g day:19 |g month:01 |g pages:451-462 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11096-023-01681-y |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 46 |j 2024 |e 2 |b 19 |c 01 |h 451-462 | ||